Back to Trades
Dolsten Mikael
DirectorCIK 0001437590
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 3
- Active
- 2025–2026
Dolsten Mikael, Director, has filed 6 SEC reports (2025–2026), spread across 3 companies, totaling $1.4M in disclosed volume. Weighing $0 bought versus $702.2K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Sep 9 | A AGILENT TECHNOLOGIES, INC. | Dolsten Mikael | Director | Sell | $96.0K |
| Jul 6 | RCKT ROCKET PHARMACEUTICALS, INC. | Dolsten Mikael | Insider | Grant | $217.3K |
| Jun 2 | A AGILENT TECHNOLOGIES, INC. | Dolsten Mikael | Director | Sell | $216.7K |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Dolsten Mikael | Insider | Disposed | $505.9K |
| Dec 3 | A AGILENT TECHNOLOGIES, INC. | Dolsten Mikael | Director | Sell | $389.5K |
| Jul 18 | RCKT ROCKET PHARMACEUTICALS, INC. | Dolsten Mikael | Insider | Grant | $0 |
6 filings